10-Q: Quarterly report
RW: Registration Withdrawal Request
Titan Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Sire Group Ltd.(14.1%),Seow Gim Shen(14.1%)
Titan Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Mokhtar Firdauz
Titan Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Flores Francisco
Titan Pharmaceuticals | 8-K: Current report
Titan Pharmaceuticals | 10-K: Annual report
Titan Pharmaceuticals | 8-K: Current report
Titan Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-10% Owner Choong Choon Hau
Titan Pharmaceuticals | 8-K: Current report
Titan Pharmaceuticals | 8-K: Current report
Titan Pharmaceuticals | 8-K: Current report
Titan Pharmaceuticals | 8-K: Current report
Titan Pharmaceuticals | 8-K: Current report
Titan Pharmaceuticals | 8-K: Current report
Titan Pharmaceuticals | DEF 14A: Definitive information statements
Titan Pharmaceuticals | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Titan Pharmaceuticals | 8-K: Current report
Titan Pharmaceuticals: Q3 2023 Earnings Report
Titan Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director NATAN DAVID
No Data